European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies

Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies

(2012) Martin Hoenigl et al.   MEDICAL MYCOLOGY

Underestimating the Real Burden of Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients?

(2010) Martin Hoenigl et al.   CLINICAL INFECTIOUS DISEASES

The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients

(2010) S. Perkhofer et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Optimizing management of invasive mould diseases

(2010) S. Agrawal et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients

(2010) L. Pagano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies

(2010) M. Hoenigl et al.   MYCOSES

Trends in invasive fungal infections, with emphasis on invasive aspergillosis

(2009) Z. Erjavec et al.   CLINICAL MICROBIOLOGY AND INFECTION

Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

(2009) Sotirios Tsiodras et al.   MAYO CLINIC PROCEEDINGS

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES